Semler Scientific rises on workforce reduction plans, Q2 rev outlook

Semler Scientific

11/07/2023 16:03

** Shares of medical technology solutions provider Semler
Scientific Inc  SMLR.O  up 4.5% at $26.63
    ** Company plans to streamline operations and reduce
employee headcount by about 30% by Sept. 15
    ** Company expects Q2 revenue to be the highest quarterly
revenue in history, driven by continued sales of QuantaFlo to
existing and new customers to test for peripheral arterial
disease
    ** Company's flagship product QuantaFlo, patented and
cleared by the U.S. FDA, is a rapid point-of-care test that
measures arterial blood flow in the extremities
    ** Appoints Renae Cormier as CFO, effective July 10
    ** Shares down 19.4% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))